HYPOMAGNESEMIA AND HYPOCALCEMIA IN A PATIENT WITH OVARIAN-CARCINOMA

被引:2
|
作者
LEESE, GP [1 ]
JUNG, RT [1 ]
BROWNING, MCK [1 ]
机构
[1] UNIV DUNDEE, NINEWELLS HOSP & MED SCH, DEPT BIOCHEM MED, DUNDEE DD1 9SY, SCOTLAND
关键词
D O I
10.1136/pgmj.69.813.583
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A patient with disseminated ovarian carcinoma presented with symptoms of hypocalcaemia secondary to hypomagnesaemia. The low serum magnesium (0.4 mmol/1) appeared to be due to renal leakage with no evidence of ureteric obstruction or hydronephrosis on intravenous urogram. Parathyroid hormone activity (serum levels and cAMP response) was normal, despite hypomagnesaemia. The patient's complaints resolved after magnesium and calcium supplementation. Hypomagnesaemia of malignancy is a rare but important complication, and is both poorly recognized and understood.
引用
收藏
页码:583 / 585
页数:3
相关论文
共 50 条
  • [31] PROGNOSTIC FACTORS IN OVARIAN-CARCINOMA
    MEERPOHL, HG
    ONKOLOGIE, 1985, 8 (05): : 296 - +
  • [32] SYSTEMIC AMYLOIDOSIS AND OVARIAN-CARCINOMA
    FERNANDEZMIRANDA, C
    MATEO, S
    GONZALEZGOMEZ, C
    BALLESTIN, C
    POSTGRADUATE MEDICAL JOURNAL, 1994, 70 (825) : 505 - 506
  • [33] RESTAGING OF PATIENTS WITH OVARIAN-CARCINOMA
    DEPALO, G
    KENDA, R
    LUINI, A
    SPINELLI, P
    PILOTTI, S
    MUSUMECI, R
    OBSTETRICS AND GYNECOLOGY, 1981, 57 (01): : 96 - 98
  • [34] PROGRESS IN CHEMOTHERAPY OF OVARIAN-CARCINOMA
    HONETZ, N
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 1982, 132 (13-1) : 319 - 324
  • [35] HYDRONEPHROSIS IN ADVANCED OVARIAN-CARCINOMA
    LUND, B
    HANSEN, HH
    GYNECOLOGIC ONCOLOGY, 1989, 35 (01) : 27 - 30
  • [36] BETAGLUCURONIDASE ACTIVITY IN OVARIAN-CARCINOMA
    HOFMANN, KD
    WAGNER, F
    DZIAMBOR, H
    PREIBSCH, W
    MULLER, HJ
    ZENTRALBLATT FUR GYNAKOLOGIE, 1979, 101 (15): : 950 - 952
  • [37] CHARACTERIZATION OF A HUMAN OVARIAN-CARCINOMA
    ROTMENSCH, J
    SCHWARTZ, JL
    BECKETT, MA
    GRDINA, DJ
    TOOHILL, P
    WEISCHELBAUM, RR
    ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1989, 11 (05): : 324 - 330
  • [38] INTRAPERITONEAL CHEMOTHERAPY FOR OVARIAN-CARCINOMA
    MARKMAN, M
    BIOMEDICINE & PHARMACOTHERAPY, 1987, 41 (08) : 420 - 424
  • [39] INTRAPERITONEAL CHEMOTHERAPY FOR OVARIAN-CARCINOMA
    SHEPARD, RC
    JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (05) : 685 - 686
  • [40] SERUM COPPER IN OVARIAN-CARCINOMA
    JACOBS, AJ
    SOMMERS, GM
    AXELROD, JH
    GALAKATOS, AE
    KAO, MS
    CAMEL, HM
    CANCER, 1988, 61 (05) : 1015 - 1017